MC Prot Biotechnology
Medical Care Proteomics Biotechnology Co.,Ltd. is a biotech venture founded based on research achievements from Kanazawa Medical University. The company applies proteomics technology to contribute to society in personalized medicine and health management. They possess cutting-edge proteomics techniques to elucidate disease causes and drug effects at the protein level, aiming to apply clinical proteomics research results to medical treatment and health management.
Industries
Nr. of Employees
small (1-50)
MC Prot Biotechnology
Ishikawa Prefecture, Kanazawa Medical University Research Institute, 1-1 Daigaku, Uchinada Town, Kanazawa City, Ishikawa, Japan
Products
Nutraceutical beverage (fish-derived collagen, biotin, dietary fiber)
Low-calorie (approx. 44 kcal per 125 mL) nutritional beverage formulated with fish-derived collagen peptides, biotin, and dietary fiber; developed with hospital nutrition guidance and used in clinical nutrition settings.
Fish-derived collagen tripeptide supplement
Supplement product containing fish-derived collagen tripeptides (approx. 15% tripeptide content) intended for beauty and general wellness support.
Nutraceutical beverage (fish-derived collagen, biotin, dietary fiber)
Low-calorie (approx. 44 kcal per 125 mL) nutritional beverage formulated with fish-derived collagen peptides, biotin, and dietary fiber; developed with hospital nutrition guidance and used in clinical nutrition settings.
Fish-derived collagen tripeptide supplement
Supplement product containing fish-derived collagen tripeptides (approx. 15% tripeptide content) intended for beauty and general wellness support.
Services
Custom proteomics projects including marker discovery, identification, and collaborative research with medical institutions and pharmaceutical companies.
Quantitative assays for specific peptides/proteins (including hepcidin variants) in serum, urine, and other biological samples.
Mass analysis services for serum, urine, cerebrospinal fluid, saliva, milk and other biological specimens.
Guidance and handling services for submission, storage (-80°C retention for 6 months), labeling, and cold-chain shipment of specimens.
Joint research agreements and R&D collaborations for drug-candidate exploration and medical-material development.
Custom proteomics projects including marker discovery, identification, and collaborative research with medical institutions and pharmaceutical companies.
Quantitative assays for specific peptides/proteins (including hepcidin variants) in serum, urine, and other biological samples.
Mass analysis services for serum, urine, cerebrospinal fluid, saliva, milk and other biological specimens.
Guidance and handling services for submission, storage (-80°C retention for 6 months), labeling, and cold-chain shipment of specimens.
Joint research agreements and R&D collaborations for drug-candidate exploration and medical-material development.
Expertise Areas
- Proteomics
- Biomarker discovery and validation
- Targeted peptide quantification
- Bioanalytical testing of multiple biofluids
Key Technologies
- Mass spectrometry-based proteomics
- Targeted peptide quantification assays
- Post-translational modification analysis
- Target protein purification and identification
News & Updates
New Release: Emitage Fact
On July 1, 2019, the company announced the release of Emitage Fact.
Website Renewal
On July 1, 2019, the company renewed its website.
Blood Journal Publication of Hepcidin Measurement Method
A paper on the measurement of hepcidin was published in Blood journal on August 15, 2006.
Award for Most Excellent Entrepreneur in Ishikawa
Received the Most Excellent Entrepreneur Award at the Ishikawa Venture Business Contest on October 7, 2008.
Joint Research with Chugai Pharmaceutical and others
Entered into joint research agreements with Chugai Pharmaceutical and other companies for drug candidate exploration and medical device material development.
New Release: Emitage Fact
On July 1, 2019, the company announced the release of Emitage Fact.
Website Renewal
On July 1, 2019, the company renewed its website.
Blood Journal Publication of Hepcidin Measurement Method
A paper on the measurement of hepcidin was published in Blood journal on August 15, 2006.
Award for Most Excellent Entrepreneur in Ishikawa
Received the Most Excellent Entrepreneur Award at the Ishikawa Venture Business Contest on October 7, 2008.
Joint Research with Chugai Pharmaceutical and others
Entered into joint research agreements with Chugai Pharmaceutical and other companies for drug candidate exploration and medical device material development.